Phase II study of temsirolimus and erlotinib in patients (pts) with recurrent/metastatic (R/M), platinum-refractory head and neck squamous cell carcinoma (HNSCC).
Julie E. Bauman
Research Funding - Genentech; Pfizer
Hugo Arias-Pulido
No relevant relationships to disclose
Sang-Joon Lee
No relevant relationships to disclose
Michael Considine
No relevant relationships to disclose
M Houman Fekrazad
No relevant relationships to disclose
Jason Howard
No relevant relationships to disclose
Justin A. Bishop
No relevant relationships to disclose
Garth T Olson
No relevant relationships to disclose
Dennie V. Jones
Consultant or Advisory Role - Roche/Genentech
Elana J. Fertig
No relevant relationships to disclose
Christine H. Chung
Research Funding - Bayer